Edwards Lifesciences Corp reports results for the quarter ended June 30 - Earnings Summary

Edwards Lifesciences

23/07/2026 22:41

Edwards Lifesciences Corp EW.N reported quarterly adjusted earnings of 78 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 67 cents.  The mean expectation of twenty five analysts for the quarter was for earnings of 74 cents per share. Wall Street expected results to range from 73 cents to 76 cents per share.
Revenue rose 13.6% to $1.74 billion from a year ago; analysts expected $1.70 billion. 
Edwards Lifesciences Corp's reported EPS for the quarter was 42 cents​.
The company reported quarterly net income of $241.9 million.
Edwards Lifesciences Corp shares had fallen by 6.7% this quarter and lost 1.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 0.4% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 21 "strong buy" or "buy," 11 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for Edwards Lifesciences Corp is $99.50, about 15.8% above its last closing price of $83.82
This summary was machine generated from LSEG data July 23 at 09:41 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.74
0.78
Beat
Mar. 31 2026 
0.73
0.78
Beat
Dec. 31 2025 
0.62
0.58
Missed
Sep. 30 2025 
0.59
0.67
Beat